Benefit and harm from immunity to respi… [Curr Opin Infect Dis. 2012] – PubMed – NCBI
See on Scoop.it – Virology and Bioinformatics from Virology.ca
Human respiratory syncytial virus (RSV) infection is a major cause of morbidity in children and of morbidity and mortality in elderly or immunocompromised adults. Given prophylactically, antibody can protect against infection, but natural levels are poorly protective. Vaccination may enhance disease, and there is no well tolerated and effective vaccine or antiviral treatment. Despite over 50 years of research, therapy remains nonspecific and supportive.
See on www.ncbi.nlm.nih.gov
